Vipin Kondath
Known title: Chief Accounting OfficerCIK: 0002100897
Associated companies
Transaction History
| VEEV | ▲ Buy | Option Exercise | 168 | $0 | 10/1/2026 | View on chart |
| VEEV | ▼ Sell | Tax Withholding | 61 | $17K | 10/1/2026 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 167 | $0 | 7/1/2026 | View on chart |
| VEEV | ▼ Sell | Tax Withholding | 60 | $11K | 7/1/2026 | View on chart |
| VEEV | ▼ Sell | Tax Withholding | 43 | $7K | 4/1/2026 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 2,500 | $0 | 4/1/2026 | View on chart |
| VEEV | ▼ Sell | Tax Withholding | 914 | $158K | 4/1/2026 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 103 | $0 | 4/1/2026 | View on chart |
| VEEV | ▼ Sell | Tax Withholding | 43 | $10K | 1/1/2026 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 103 | $0 | 1/1/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Veeva Gains Investor Attention Amid R&D Growth and AI Focus
Veeva Systems is drawing investor interest as analysts note strong R&D growth and a positive outlook. The company has secured a major research partner that now uses its software as the default clinical platform, and a recent IQVIA deal expands its market reach. Large institutional investors are also increasing exposure to Veeva as part of an AI software play.
Veeva Gains Investor Attention Amid R&D Growth and AI Focus. Veeva Systems is drawing investor interest as analysts note strong R&D growth and a positive outlook. The company has secured a major research partner that now uses its software as the default clinical platform, and a recent IQVIA deal expands its market reach. Large institutional investors are also increasing exposure to Veeva as part of an AI software play.